Literature DB >> 33910816

A Potential Pathogenic Link Between Cancer of Female Reproductive System and Infertile Women Treated With Assisted Reproduction Techniques.

Michail Diakosavvas1, Zacharias Fasoulakis1, Thomas Ntounis1, Antonios Koutras2, Kyveli Angelou1, Georgios Tsatsaris2, Athanasios Syllaios3, Nikolaos Garmpis4, Emmanuel N Kontomanolis2.   

Abstract

Prevention and treatment of infertility remains a priority for developed countries where a large proportion of women undergo in vitro fertilization (IVF) after ovarian stimulation. Latest data suggest that, in the USA alone, almost eight million women of fertile age will have sought medical advice for fertility problems by 2025. However, over the last years, attention has been increasingly focused, and questions have risen, on the long-term health effects in women who underwent assisted reproductive technologies (ARTs). Since the emergence of ART, reports highlight a possible connection of ovarian stimulation and several types of gynaecological cancer, including ovarian, endometrial and cervical types, but due to limited scientific evidence, such a speculation is still under investigation. The objective of this review is to summarize the latest data of ovarian hyperstimulation and IVF, associated with the risk of gynecological tract cancer development. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Assisted reproduction technology; endometrial; fertility drugs; gynecological cancer; ovarian; review

Mesh:

Year:  2021        PMID: 33910816      PMCID: PMC8193339          DOI: 10.21873/invivo.12391

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  33 in total

1.  Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.

Authors:  Britton Trabert; Emmet J Lamb; Bert Scoccia; Kamran S Moghissi; Carolyn L Westhoff; Shelley Niwa; Louise A Brinton
Journal:  Fertil Steril       Date:  2013-09-05       Impact factor: 7.329

2.  Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Authors:  A Venn; L Watson; F Bruinsma; G Giles; D Healy
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

3.  Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.

Authors:  Sarah Marie Bjørnholt; Susanne Krüger Kjaer; Thor Schütt Svane Nielsen; Allan Jensen
Journal:  Hum Reprod       Date:  2014-11-05       Impact factor: 6.918

4.  Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers.

Authors:  Tamar Perri; Dror Lifshitz; Siegal Sadetzki; Bernice Oberman; Dror Meirow; Gilad Ben-Baruch; Eitan Friedman; Jacob Korach
Journal:  Fertil Steril       Date:  2015-03-16       Impact factor: 7.329

5.  Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.

Authors:  R Fanchin; C Righini; F Olivennes; S Taylor; D de Ziegler; R Frydman
Journal:  Hum Reprod       Date:  1998-07       Impact factor: 6.918

6.  Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion.

Authors:  Elizabeth R Smith; Xiang-Xi Xu
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

7.  Ovarian tumors in a cohort of infertile women.

Authors:  M A Rossing; J R Daling; N S Weiss; D E Moore; S G Self
Journal:  N Engl J Med       Date:  1994-09-22       Impact factor: 91.245

Review 8.  Does fertility treatment increase the risk of uterine cancer? A meta-analysis.

Authors:  Srdjan Saso; Louay S Louis; Farah Doctor; Ali Hassan Hamed; Jayanta Chatterjee; Joseph Yazbek; Shabana Bora; Hossam Abdalla; Sadaf Ghaem-Maghami; Meen-Yau Thum
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-10-03       Impact factor: 2.831

Review 9.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

10.  Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

Authors:  I dos Santos Silva; P A Wark; V A McCormack; D Mayer; C Overton; V Little; J Nieto; P Hardiman; M Davies; A B MacLean
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.